149 related articles for article (PubMed ID: 7040465)
1. Evaluation of fluorescent antinuclear antibody assays, Crithidia luciliae substrate, and single-stranded DNA-binding capacity in diagnosis of four rheumatic diseases.
Chiang M; Chia D; Barnett EV
J Clin Microbiol; 1982 Apr; 15(4):684-7. PubMed ID: 7040465
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to native DNA in connective tissue disease. A comparison of radioimmunoassay, counterimmunoelectrophoresis and indirect immunofluorescence on Crithidia luciliae substrate.
Hodinka L; Merétey K; Jancsó A; Falus A; Korda J; Bozsóky S
Arch Immunol Ther Exp (Warsz); 1979; 27(5):641-6. PubMed ID: 398205
[TBL] [Abstract][Full Text] [Related]
3. The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus.
Burdash NM; Teti G; Papadopoulos V
Ann Clin Lab Sci; 1983; 13(1):49-54. PubMed ID: 6340594
[TBL] [Abstract][Full Text] [Related]
4. [Anti-DNA determination using Crithidia luciliae. Specificity and clinical usefulness in systemic lupus erythematosus].
Pena Sagredo JL; Orte Martinez FJ; Sanchez Andrada S; Sampedro Alvarez J; Novo Fernandez MJ; Rodriguez Valverde V
Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):345-50. PubMed ID: 7048503
[TBL] [Abstract][Full Text] [Related]
5. [Determination of anti dsDNA antibodies by immunofluorescence using Crithidia luciliae. I--Diagnostic and prognostic value in systemic lupus erythematosus. Comparison with the Farr radioimmunoassay].
Borda-Iriarte O; Meyer O; Cyna J; Haïm T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):185-91. PubMed ID: 6374861
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique.
Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of systemic lupus erythematosus in Jamaica by Crithidia luciliae indirect immunofluorescence test.
Fisher-Smikle M; James OB
Trans R Soc Trop Med Hyg; 1987; 81(2):255-6. PubMed ID: 3303482
[TBL] [Abstract][Full Text] [Related]
8. The Crithidia luciliae immunofluorescent test for the detection of antibodies to native DNA.
Mauff AC
S Afr Med J; 1981 Jan; 59(3):69-70. PubMed ID: 7008212
[TBL] [Abstract][Full Text] [Related]
9. Mixed connective tissue disease.
Brook AS
Aust N Z J Med; 1978; 8 Suppl 1():130-3. PubMed ID: 310295
[No Abstract] [Full Text] [Related]
10. Specificity of the hydrochloric-acid-modified Crithidia luciliae immunofluorescence assay for detection of antibody to native DNA.
Henderson T; Medsger TA; Sontheimer RD; Harmon CE; Deng JS
Diagn Clin Immunol; 1987; 5(1):20-4. PubMed ID: 3297382
[TBL] [Abstract][Full Text] [Related]
11. [Kinetoplast of Crithidia luciliae as a substrate for demonstrating antibodies against native DNA in systemic lupus erythematosus].
Herrera-Esparza R; Escobar-Luján M; Avalos-Díaz E; Guzmán-Enríquez L
Bol Med Hosp Infant Mex; 1983 Apr; 40(4):208-11. PubMed ID: 6347221
[No Abstract] [Full Text] [Related]
12. Comparison of commercial kits for the detection of anti-nDNA antibodies using Crithidia luciliae.
Jansen EM; Deng JS; Beutner EH; Kumar V; Chorzelski TP
Am J Clin Pathol; 1987 Apr; 87(4):461-9. PubMed ID: 3548319
[TBL] [Abstract][Full Text] [Related]
13. [Kinetoplast of the flagellate crithidia luciliae: a suitable substrate for the detection of antibodies to native, double-stranded DNA in the indirect immuno-fluorescence test (author's transl)].
Stingl G; Knapp W
Wien Klin Wochenschr; 1975 Dec; 87(24):827-9. PubMed ID: 775803
[TBL] [Abstract][Full Text] [Related]
14. Specificity of the Crithidia luciliae method for detecting anti-DNA antibodies. Effect of absorption for lipoproteins.
Kumar V; Krasny S; Beutner EH
Immunol Invest; 1985 Jun; 14(3):199-210. PubMed ID: 2995252
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus and the crithidia luciliae immunofluorescent test. A comparative study with an adapted Farr radioimmunoassay.
Whitehouse IJ; Fehr K; Wagenhäuser FJ
Z Rheumatol; 1983; 42(1):28-35. PubMed ID: 6342296
[TBL] [Abstract][Full Text] [Related]
16. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity.
Haugbro K; Nossent JC; Winkler T; Figenschau Y; Rekvig OP
Ann Rheum Dis; 2004 Apr; 63(4):386-94. PubMed ID: 15020332
[TBL] [Abstract][Full Text] [Related]
17. The detection of double stranded DNA antibody using human metaphase chromosomes.
Somerfield SD; Wilson JD
J Clin Lab Immunol; 1980 May; 3(3):203-7. PubMed ID: 6999159
[TBL] [Abstract][Full Text] [Related]
18. Diseases in which antinuclear antibody and-or rheumatoid factor are usually present. (Rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis).
Sheon RP; Kirsner AB
Med Times; 1973 Feb; 101(2):97-113. PubMed ID: 4539866
[No Abstract] [Full Text] [Related]
19. Diagnosis of systemic lupus erythematosus. Importance of antinuclear antibody titers and peripheral staining patterns.
Nisengard RJ; Jablonska S; Chorzelski TP; Blaszcyk M; Jarret C; Beutner EH
Arch Dermatol; 1975 Oct; 111(10):1298-300. PubMed ID: 54050
[TBL] [Abstract][Full Text] [Related]
20. Anti-native DNA detection by the Crithidia luciliae method: an improved guide to the diagnosis and clinical management of systemic lupus erythematosus.
Ballou SP; Kushner I
Arthritis Rheum; 1979 Apr; 22(4):321-7. PubMed ID: 371628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
